Veradermics, Incorporated
MANE
$99.69
-$4.14-3.99%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.48% | 85.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.03% | 29.77% | |||
| Operating Income | 1.03% | -29.77% | |||
| Income Before Tax | 13.70% | -24.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.70% | -24.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.70% | -24.65% | |||
| EBIT | 1.03% | -29.77% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 56.03% | 96.49% | |||
| Normalized Basic EPS | 51.53% | 95.88% | |||
| EPS Diluted | 56.03% | 96.49% | |||
| Normalized Diluted EPS | 51.53% | 95.88% | |||
| Average Basic Shares Outstanding | 78.10% | 2,928.02% | |||
| Average Diluted Shares Outstanding | 78.10% | 2,928.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||